Literature DB >> 10980428

GSK3, a master switch regulating cell-fate specification and tumorigenesis.

L Kim1, A R Kimmel.   

Abstract

Until recently, protein kinase GSK3 (glycogen synthase kinase 3), an essential component for cell-fate specification, had been considered a constitutively activated enzyme subject to developmentally regulated inhibition through hierarchical, linear signaling paths. Data from various systems now indicate more complex scenarios involving activating as well as inhibiting circuits, and the differential formation of multi-protein complexes that antagonistically affect GSK3 function.

Mesh:

Substances:

Year:  2000        PMID: 10980428     DOI: 10.1016/s0959-437x(00)00120-9

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  57 in total

1.  Expression profiling of the whole Arabidopsis shaggy-like kinase multigene family by real-time reverse transcriptase-polymerase chain reaction.

Authors:  Bénédicte Charrier; Anthony Champion; Yves Henry; Martin Kreis
Journal:  Plant Physiol       Date:  2002-10       Impact factor: 8.340

2.  Combinatorial cell-specific regulation of GSK3 directs cell differentiation and polarity in Dictyostelium.

Authors:  Leung Kim; Joseph Brzostowski; Amit Majithia; Nam-Sihk Lee; Vanessa McMains; Alan R Kimmel
Journal:  Development       Date:  2011-02       Impact factor: 6.868

3.  Brassinosteroids.

Authors:  Steven D Clouse
Journal:  Arabidopsis Book       Date:  2011-11-02

4.  Isolation and expression analysis of tuberous root development related genes in Rehmannia glutinosa.

Authors:  Peng Sun; Yuhai Guo; Jianjun Qi; Lili Zhou; Xianen Li
Journal:  Mol Biol Rep       Date:  2010-02       Impact factor: 2.316

5.  Phosphorylation of the cytoskeletal protein CAP1 controls its association with cofilin and actin.

Authors:  Guo-Lei Zhou; Haitao Zhang; Huhehasi Wu; Pooja Ghai; Jeffrey Field
Journal:  J Cell Sci       Date:  2014-10-14       Impact factor: 5.285

6.  Regulation of proteolytic cleavage of retinoid X receptor-α by GSK-3β.

Authors:  Weiwei Gao; Jie Liu; Mengjie Hu; Mingfeng Huang; Sisi Cai; Zhiping Zeng; Bingzhen Lin; Xihua Cao; Jiebo Chen; Jin-zhang Zeng; Hu Zhou; Xiao-kun Zhang
Journal:  Carcinogenesis       Date:  2013-02-06       Impact factor: 4.944

7.  Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.

Authors:  Mohamed Rahmani; Mandy Mayo Aust; Elisa Attkisson; David C Williams; Andrea Ferreira-Gonzalez; Steven Grant
Journal:  Cancer Res       Date:  2012-12-12       Impact factor: 12.701

8.  Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3beta is implicated in the treatment of cervical carcinoma.

Authors:  Yuan Zhang; Yi Min Shu; Shu Fang Wang; Bang Hong Da; Ze Hua Wang; Hua Bin Li
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

9.  Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8.

Authors:  Diana Aguilar-Morante; Jose Angel Morales-Garcia; Marina Sanz-SanCristobal; Miguel Angel Garcia-Cabezas; Angel Santos; Ana Perez-Castillo
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

10.  Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.

Authors:  Chandra P Prasad; Gayatri Rath; Sandeep Mathur; Dinesh Bhatnagar; Rajinder Parshad; Ranju Ralhan
Journal:  BMC Cancer       Date:  2009-09-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.